Latest KFF Health News Stories
Arkansas’ Governor Says Medicaid Extension for New Moms Isn’t Needed
Federal law requires states to provide pregnancy-related Medicaid coverage through 60 days after delivery. Arkansas has not expanded what’s called postpartum Medicaid coverage, an option that gives poor women uninterrupted health insurance for a year after they give birth.
California May Regulate and Restrict Pharmaceutical Brokers
California lawmakers are moving to rein in the pharmaceutical middlemen they say drive up costs and limit consumers’ choices. The bill sent to Gov. Gavin Newsom would require pharmacy benefit managers to be licensed in California and would ban some business practices. Newsom vetoed a previous effort three years ago.
Tennessee Tries To Rein In Ballad’s Hospital Monopoly After Years of Problems
Ballad Health, a 20-hospital system with the nation’s largest state-sanctioned hospital monopoly, serves patients in Tennessee, Virginia, Kentucky, and North Carolina.
Décadas de programas nacionales contra el suicidio no han frenado estas muertes
Durante los últimos 20 años, funcionarios federales han lanzado tres estrategias nacionales de prevención del suicidio, incluida una anunciada en abril.
Decades of National Suicide Prevention Policies Haven’t Slowed the Deaths
Despite years of national strategies to address the suicide crisis in the U.S., rates continue to rise. A chorus of researchers and experts say the interventions will work — but that they’re simply not being adopted by state and local governments.
Forget Repeal and Replace. The Next Big ACA Fight Will Be Over Subsidies.
Forget repeal and replace. Critics of the Affordable Care Act, a.k.a. Obamacare, have a new target: key parts of the law that they say are too costly and provide incentive for fraud. Topping that list are the ACA’s enhanced subsidies, put in place during the coronavirus pandemic as part of economic recovery legislation and set to […]
US Uninsured Rate Was Stable in 2023, Even as States’ Medicaid Purge Began
About 8% of Americans lacked health insurance in 2023, the Census Bureau announced. But its report doesn’t capture the effect of states winnowing their Medicaid rolls by millions of people since the pandemic emergency ended.
La tasa de personas sin seguro médico se mantiene estable, a pesar de la purga de Medicaid
Aproximadamente el 8% de los estadounidenses no tuvieron cobertura en 2023, un aumento estadísticamente insignificante de solo 0.1 puntos porcentuales con respecto al año anterior.
Harris and Trump Are Ready To Take on Big Pharma
Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars this election season. When Harris was California’s attorney general, she joined cases that resulted in almost $7.2 billion (about $22 per person in the United […]
ACA Enrollment Platforms Suspended Over Alleged Foreign Access to Consumer Data
Federal regulators provided more specifics about why they suspended two private sector Affordable Care Act enrollment sites, including concerns about potential overseas accessing of consumer data and suspicions of involvement in Obamacare enrollment and switching schemes. The companies reject the assertions.
With TV Drug Ads, What You See Is Not Necessarily What You Get
The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.
En los comerciales de medicamentos en TV, lo que ves no siempre es lo que es
Los anuncios de medicamentos han sido omnipresentes en la televisión desde finales de la década de 1990 y se han extendido a internet y las redes sociales. Pocas naciones en el mundo los permiten
Patients Suffer When Indian Health Service Doesn’t Pay for Outside Care
The Indian Health Service has a program that can pay for outside appointments when patients need care not offered at agency-funded sites. Critics say money shortages, complex rules, and administrative fumbles often block access, however.
Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health
State leaders are cutting public health spending and laying off workers hired during a pandemic-era grant boom. Public health officials say the bust will erode important advancements in the public health safety net, particularly in rural areas.
Errors in Deloitte-Run Medicaid Systems Can Cost Millions and Take Years To Fix
As states wait for Deloitte to make fixes in computer systems, Medicaid beneficiaries risk losing access to health care and food.
Del auge a la caída: falta de dinero y despidos golpean a la salud pública
Ante la pandemia, el Congreso asignó más de $800 mil millones para fortalecer la respuesta de los estados ante covid. Esto resultó en un notable aumento del número de trabajadores de salud pública en todo el país. Ese dinero se ha esfumado.
Tribal Health Officials ‘Blinded’ by Lack of Data
A strong public health system can make a big difference for those who face stark health disparities. But epidemiologists serving Native American communities, which have some of the nation’s most profound health inequities, say they’re hobbled by state and federal agencies restricting their access to important data. American Indians and Alaska Natives face life expectancy […]
Feds Killed Plan To Curb Medicare Advantage Overbilling After Industry Opposition
A private 2014 decision by the Centers for Medicare & Medicaid Services faces new scrutiny in a multibillion-dollar Justice Department fraud case against UnitedHealth Group.
An Arm and a Leg: Don’t Get ‘Bullied’ Into Paying What You Don’t Owe
In this episode of “An Arm and a Leg,” host Dan Weissmann speaks with Caitlyn Mai, a woman in Oklahoma who received a six-figure bill for a surgery her insurance promised to cover. This episode is an extended version of the “Bill of the Month” series, produced in partnership with NPR.
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
